✦ LIBER ✦

Expert Commentary: Practical Issues in Newborn Screening for Severe Combined Immune Deficiency (SCID)

✍ Scribed by Jennifer M. Puck; Jack Routes; Alexandra H. Filipovich; Kate Sullivan

Publisher: Springer
Year: 2011
Tongue: English
Weight: 72 KB
Volume: 32
Category: Article
ISSN: 0271-9142
DOI: 10.1007/s10875-011-9598-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of (S)-1-(3-hydroxy-2-phosphony

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

✍ Johan Neyts; Erik De Clercq 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

## Abstract Severe combined immune deficient (SCID) mice inoculated intravenously with vaccinia virus (VV) became sick within 6–8 days and died 10–12 days after infection. Tail lesions developed and the number depended on the virus inoculum. Age‐matched immunocompetent NMRI mice similarly infected

Report of a second serious adverse event

Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID) : Position of the European Society of Gene Therapy (ESGT)

✍ Bernd Gansbacher 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

French gene therapy group reports on the

French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID) : Position statement from the European Society of Gene Therapy (ESGT)

📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

## Position statement from the European Society of Gene Therapy (ESGT) Background News of a serious adverse event in a clinical trial of gene therapy for inherited, X chromosome-linked Severe Combined Immunodeficiency (X-SCID) was made public on October 2, 2002, by the group of French scientists p